SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma informs about closure of trading window

04 Apr 2019 Evaluate

With reference to the circulars issued by BSE vide Circular no. LIST/COMP/01/2019-20 and NSE vide Circular no. NSE/CML/2019/11 dated April 2, 2019 pertaining to clarification regarding trading restriction period.  In complying with the aforesaid circulars and pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, Bliss GVS Pharma has informed that the Trading window for dealing in securities/shares of the Company will remain closed for all the Designated Persons and their immediate relatives of the Company with immediate effect (i.e. April 4, 2019) until 48 hours after the announcement of the financial results of the Company for the quarter and financial year ended March 31, 2019.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

269.35 -2.55 (-0.94%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×